Ganciclovir CAS 82410-32-0 API BW 759 GCV Antiviral CMV Inhibitor High Quality

Inkcazelo emfutshane:

Igama leMichiza: Ganciclovir

CAS: 82410-32-0

Imbonakalo: Mhlophe ukuya kuMhlophe-Mhlophe wePowder

Uvavanyo: 98.0% ~ 102.0%

I-Agent Antiviral Unyango lwe-Cytomegalovirus (CMV) Usulelo

Umgangatho ophezulu we-API, iMveliso yoRhwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo lwabavelisi ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
Igama leMichiza: Ganciclovir
CAS: 82410-32-0
I-Agent ye-Antiviral yoNyango lwe-Cytomegalovirus (CMV) Infection
Umgangatho ophezulu we-API, iMveliso yoRhwebo

Iipropati zeMichiza:

Igama leMchiza	Ganciclovir
Izithethantonye	GCV;BW 759;9-[[2-Hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine;I-2-Amino-9- (1,3-dihydroxypropan-2-yloxymethyl) -3H-purin-6-enye;2'-Nor-2'-Deoxyguanosine
Inombolo yeCAS	82410-32-0
Inombolo yeCAT	RF-API82
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	I-C9H13N5O4
Ubunzima beMolekyuli	255.23
Indawo yokunyibilika	250℃
Ubushushu boGcino	2-8℃
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Mhlophe ukuya kuMhlophe oMhlophe wePowder
Ukunyibilika	Kancinci kakhulu ukuNyibilika emanzini
Ukuchongwa	Ukufunxwa kwe-Ultraviolet, i-Infrared Absorption
Ilahleko ekomisweni	≤6.0%
Intsalela kwi-Ignition	≤0.10%
Izinto ezinxulumeneyo	I-Ganciclovir Related Compound A ≤0.50%
Umda weGuanine	≤0.50%
Intsalela yezinyibilikisi (GC)	I-Ethanol ≤5000ppm
Iintsimbi ezinzima	≤10ppm
I-Coefficient yokufunxa	516-548 kwi-252nm
Iintsholongwane ze-Endotoxins	≤0.84EU/mg
Isivavanyi	98.0%~102.0% (Titration)
Umgangatho woVavanyo	uMgangatho woShishino;Umgangatho we-United States Pharmacopoeia (USP).
Ukusetyenziswa	API, CMV Inhibitor

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.

Izinto eziluncedo:

FAQ:

Isicelo:

I-Ganciclovir (i-CAS 82410-32-0) iyeye-nucleoside antiviral drug, luhlobo lwe-guanosine derivatives.I-Ganciclovir yi-agent ye-antiviral esebenzayo eboniswe kwi-parenterally-active antiviral eboniswe kumbono- okanye ubomi obusongela usulelo lwe-cytomegalovirus (CMV) kwizigulana ezibuthathaka.Ine-spectrum ebanzi, i-high-efficient inhibitory effects kwi-herpes virus kwaye iyeza lokuqala lokukhetha unyango lwe-cytomegalovirus usulelo olunempembelelo enamandla kwintsholongwane ye-hepatitis B kunye ne-adenovirus ngokunjalo.Yi-homologue ye-acyclovir (ACV) kunye nefuthe layo le-antiviral efana ne, kodwa yomelele kune-aciclovir, eneziphumo ezinamandla ngakumbi zokuthintela kwi-cytomegalovirus ehambelana nezigulana zikaGawulayo.Yiklinikhi esetyenziselwa unyango lwesigaba sokungeniswa kunye nesigaba sokulondoloza kwizigulane ezingenasifo (kubandakanywa nezigulane ze-AIDS) kunye ne-cytomegalovirus retinitis.Ingasetyenziselwa ukuthintela isifo se-cytomegalovirus kwizigulane ezifumana ukutshintshwa kwamalungu okanye izigulane ze-AIDS ezineziphumo ezilungileyo kwi-cytomegalovirus serology test.

I-Ganciclovir (i-CAS 82410-32-0) yinto esebenza kakhulu, i-low-toxicity kunye ne-high-selectivity inhibitor ye-virus eyenziwe yiNkampani ye-Syntex (eUnited States).Lichiza lokuqala elivunyiweyo yi-US FDA kunyango lwe-cytomegalovirus (CMV) usulelo.I-Syntex inikwe ilungelo elilodwa lokuvelisa.NgoJuni ka-1988, le tablet yamkelwa okokuqala ngqa ukuba idweliswe e-UK, kulandelwa kukwamkelwa ngokulandelelanayo yiFransi, iUnited States, iJapan, kunye neWest Germany, i-Italiya neKhanada namanye amazwe.Kuze kube sekupheleni kukaJuni 1999, kuye kwavunywa kumazwe angaphezu kwama-70 kunye nemimandla yokuthintela izigulane ze-immunodeficiency kunye nosulelo lwe-cytomegalovirus lwezigulane ze-organ transplantation.Ngo-2002, iipilisi ze-Ganciclovir zifumene imvume ye-FDA, zifumaneka ngoku.